» Articles » PMID: 37773078

Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment

Overview
Journal Curr Oncol Rep
Publisher Current Science
Specialty Oncology
Date 2023 Sep 29
PMID 37773078
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Summarize the writings published in the last years on the management and novel therapies of mucosal melanoma (MM).

Recent Findings: New research has demonstrated a difference between MM and cutaneous melanoma (CM) in their genomic and molecular landscapes, explaining the response's heterogeneity. Immunotherapy and targeted therapy have limited benefit, but novel therapies are rapidly expanding. MM is aggressive cancer occurring in gastrointestinal, respiratory, or urogenital mucosa; whose incidence is greater in the Asian population. The etiology and pathogenesis remain unclear since UV exposure is not a proven risk factor as in cutaneous melanoma. In contrast to CM, lesions on the mucosal surface are less likely to be recognized early; therefore, the disease is diagnosed in an advanced stage. Clinical manifestations, such as bleeding or pain, can help to detect this tumor, although the prognosis remains unfavorable with an overall 5-year survival rate of less than 20%. The mutational landscape of MM includes mutations of BRAF and NRAS, as well as mutations in the c-KIT/CD117 gene (in 50% of patients), thus limiting therapeutic interventions to immunotherapy. However, clinical studies show less responsiveness to immunotherapy compared to CM, therefore novel therapeutic strategies targeting new molecules are needed to improve the survival of patients with MM.

Citing Articles

Malignant melanoma of the conjunctiva metastasizing to the submandibular gland: a case report and review of the literature.

Okongwu C, Adewara B, Olaofe O, Soremekun A, Ayodele S, Abdullahi Y BMC Ophthalmol. 2025; 25(1):130.

PMID: 40082862 PMC: 11905526. DOI: 10.1186/s12886-025-03949-5.


Primary Sinonasal Mucosal Melanoma: A Narrative Review.

Todorovic N, Djurkovic P, Krstic A, Tomanovic N, Milanovic P, Kablar D Diagnostics (Basel). 2025; 15(4).

PMID: 40002647 PMC: 11854324. DOI: 10.3390/diagnostics15040496.


Carbon-Ion Radiotherapy for Head and Neck Mucosal Melanoma: Preliminary Clinical Outcomes and the MedAustron Approach for Reporting RBE-Weighted Dose With 2 Models.

Nachankar A, Pelak M, Schafasand M, Martino G, Tubin S, Hug E Int J Part Ther. 2025; 15:100738.

PMID: 39896178 PMC: 11786705. DOI: 10.1016/j.ijpt.2025.100738.


Exploring the impact of deubiquitination on melanoma prognosis through single-cell RNA sequencing.

Peng S, Xie J, He X Front Genet. 2024; 15:1509049.

PMID: 39712483 PMC: 11659643. DOI: 10.3389/fgene.2024.1509049.


Rare Head and Neck Cancers and Pathological Diagnosis Challenges: A Comprehensive Literature Review.

Filippini D, Carosi F, Querzoli G, Fermi M, Ricciotti I, Molteni G Diagnostics (Basel). 2024; 14(21).

PMID: 39518333 PMC: 11544949. DOI: 10.3390/diagnostics14212365.


References
1.
Studentova H, Kalabova H, Koranda P, Chytilova K, Kucerova L, Melichar B . Immunotherapy in mucosal melanoma: a case report and review of the literature. Oncotarget. 2018; 9(25):17971-17977. PMC: 5915169. DOI: 10.18632/oncotarget.24727. View

2.
Massi D, Rulli E, Cossa M, Valeri B, Rodolfo M, Merelli B . The density and spatial tissue distribution of CD8 and CD163 immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors. J Immunother Cancer. 2019; 7(1):308. PMC: 6858711. DOI: 10.1186/s40425-019-0797-4. View

3.
Seetharamu N, Ott P, Pavlick A . Mucosal melanomas: a case-based review of the literature. Oncologist. 2010; 15(7):772-81. PMC: 3228004. DOI: 10.1634/theoncologist.2010-0067. View

4.
Schoenewolf N, Bull C, Belloni B, Holzmann D, Tonolla S, Lang R . Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations. Eur J Cancer. 2012; 48(12):1842-52. DOI: 10.1016/j.ejca.2012.02.049. View

5.
Cote T, Sobin L . Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin. Melanoma Res. 2009; 19(1):58-60. DOI: 10.1097/CMR.0b013e32831ef262. View